Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideki Fujii

Showing results (531-540 of 556) with videos related to

Pageof 56
Sort By:
World Journal of Gastroenterology|March 12, 2015
Stratifying the risk of lymph node metastasis in undifferentiated-type early gastric cancerYukiko Asakawa, Masahiko Ohtaka, Shinya Maekawa, et al.
Scientific Reports|July 12, 2018
A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLDTakumi Kawaguchi, Katsutoshi Tokushige, Hideyuki Hyogo, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 4, 2023
Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2014 to 2018 in Japan: A large-scale multicenter retrospective studyHideki Fujii, Yuichiro Suzuki, Koji Sawada, et al.
Gastro Hep Advances|November 19, 2024
Clinical Characteristics of Steatotic Liver Disease Categories in a Large Cohort of Japanese Health Checkup ParticipantsYoshihiro Kamada, Hideki Fujii, Yuichiro Suzuki, et al.
Hepatology (Baltimore, Md.)|February 10, 2019
Bezafibrate Improves GLOBE and UK-PBC Scores and Long-Term Outcomes in Patients With Primary Biliary CholangitisAkira Honda, Atsushi Tanaka, Tetsuji Kaneko, et al.
Alimentary Pharmacology & Therapeutics|April 23, 2024
Hepatic inflammation and fibrosis are profiles related to mid-term mortality in biopsy-proven MASLD: A multicenter study in JapanTsubasa Tsutsumi, Takumi Kawaguchi, Hideki Fujii, et al.
Clinical and Molecular Hepatology|January 24, 2024
Prognosis of biopsy-confirmed metabolic dysfunction- associated steatotic liver disease: A sub-analysis of the CLIONE studyMichihiro Iwaki, Hideki Fujii, Hideki Hayashi, et al.
Journal of Gastroenterology and Hepatology|February 17, 2023
Noninvasive tests predict liver-related events and mortality in patients with nonalcoholic fatty liver disease: sub-analysis of the CLIONE-Asia studyHiroshi Ishiba, Yoshio Sumida, Yoshihiro Kamada, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 3, 2024
Viral eradication reduces all-cause mortality in patients with chronic hepatitis C virus infection who had received direct-acting antiviral therapyToshifumi Tada, Masayuki Kurosaki, Hidenori Toyoda, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 20, 2022
Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort StudyHideki Fujii, Michihiro Iwaki, Hideki Hayashi, et al.
Pageof 56

Showing results (531-540 of 556) with videos related to

Sort By:
Pageof 56
World Journal of Gastroenterology|March 12, 2015
Stratifying the risk of lymph node metastasis in undifferentiated-type early gastric cancerYukiko Asakawa, Masahiko Ohtaka, Shinya Maekawa, et al.
Scientific Reports|July 12, 2018
A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLDTakumi Kawaguchi, Katsutoshi Tokushige, Hideyuki Hyogo, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 4, 2023
Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2014 to 2018 in Japan: A large-scale multicenter retrospective studyHideki Fujii, Yuichiro Suzuki, Koji Sawada, et al.
Gastro Hep Advances|November 19, 2024
Clinical Characteristics of Steatotic Liver Disease Categories in a Large Cohort of Japanese Health Checkup ParticipantsYoshihiro Kamada, Hideki Fujii, Yuichiro Suzuki, et al.
Hepatology (Baltimore, Md.)|February 10, 2019
Bezafibrate Improves GLOBE and UK-PBC Scores and Long-Term Outcomes in Patients With Primary Biliary CholangitisAkira Honda, Atsushi Tanaka, Tetsuji Kaneko, et al.
Alimentary Pharmacology & Therapeutics|April 23, 2024
Hepatic inflammation and fibrosis are profiles related to mid-term mortality in biopsy-proven MASLD: A multicenter study in JapanTsubasa Tsutsumi, Takumi Kawaguchi, Hideki Fujii, et al.
Clinical and Molecular Hepatology|January 24, 2024
Prognosis of biopsy-confirmed metabolic dysfunction- associated steatotic liver disease: A sub-analysis of the CLIONE studyMichihiro Iwaki, Hideki Fujii, Hideki Hayashi, et al.
Journal of Gastroenterology and Hepatology|February 17, 2023
Noninvasive tests predict liver-related events and mortality in patients with nonalcoholic fatty liver disease: sub-analysis of the CLIONE-Asia studyHiroshi Ishiba, Yoshio Sumida, Yoshihiro Kamada, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 3, 2024
Viral eradication reduces all-cause mortality in patients with chronic hepatitis C virus infection who had received direct-acting antiviral therapyToshifumi Tada, Masayuki Kurosaki, Hidenori Toyoda, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 20, 2022
Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort StudyHideki Fujii, Michihiro Iwaki, Hideki Hayashi, et al.
Pageof 56